Neonatal jaundice. Neonatal jaundice from other and unspecified causes
Conditions
Interventions
Intervention 1: Fenofibrate group: single dose of oral fenofibrate (Sobhan Co., Iran) in liquid form, containing 20 mg/ml, with a dose of 10 mg/kg was given at the time of admission. Standard photothe
Sponsors
Babol University of Medical Sciences
Eligibility
Sex/Gender
All
Age
3 Days to 28 Days
Inclusion criteria
Inclusion criteria: Term neonates(37 weeks to 41 weeks and 6 days) that their ages are more than 72 hours. They were admitted for jaundice, total bilirubin serum more than 15 mg/dl. They were otherwise healthy. They did not receive therapy other than phototherapy.
Exclusion criteria
Exclusion criteria: Premature neonates IUGR infants Neonates with congenital anomaly Neonates with blood group and RH incompatibility Neonates with G6PD deficiency Neonates with history of maternal phenobarbital consumption Neonates with respiratory distress and signs and symptoms of sepsis
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Duration of need to phototherapy and hospital stay. Timepoint: From the time of admission until discharge. Method of measurement: Duration of time by hour. | — |
Primary
| Measure | Time frame |
|---|---|
| Serum bilirubin level. Timepoint: Admission time, second day, third day, discharge time. Method of measurement: Spectrophotometric method with the biochemical kit ( made in Iran ). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMousa Ahmadpour-kacho
Babol University of Medical Sciences
Outcome results
None listed